← All trials
NCT04899765
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 20, 2021
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2027
- First posted
- May 24, 2021
- Last posted
- May 26, 2021
- Enrollment
- 2400
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bandim Health ProjectLead sponsor
- Free University of BrusselsCollaborator
- University of Western AustraliaCollaborator
- University of Southern DenmarkOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.